Previous 10 | Next 10 |
home / stock / avcnf / avcnf news
TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...
2024-02-05 08:06:02 ET More on Avicanna Inc., Avicanna, etc. Avicanna Inc. (AVCNF) Q3 2023 Earnings Call Transcript Financial information for Avicanna Inc. Financial information for Avicanna Read the full article on Seeking Alpha For further details s...
Exclusive supply agreement for two of Avicanna’s proprietary topical products in the European region Right of first refusal agreement for the Avicanna’s SEDDs capsules in the European region TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avi...
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is ...
2023-11-15 14:00:11 ET Avicanna Inc. (AVCNF) Q3 2023 Results Earnings Conference Call November 15, 2023, 08:30 AM ET Company Participants Aras Azadian - Chief Executive Officer Phillip Cardella - Chief Financial Officer Conference Call Participants Pres...
2023-11-14 17:48:37 ET More on Avicanna Financial information for Avicanna For further details see: Avicanna Non-GAAP EPS of -$0.01, revenue of $6.27M
Acquisition of Medical Cannabis by Shoppers assets leading to the launch of MyMedi.ca. Record revenue of $6.27M, representing an increase of 90% over Q2, and 713% year-over-year. Improvements in performance including 46% consolidated gross margins and adjusted EBITDA of ($400k) ...
TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and a medical cannabis care platform ...
TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based product...
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is please...
News, Short Squeeze, Breakout and More Instantly...
Avicanna Inc Company Name:
AVCNF Stock Symbol:
OTCMKTS Market:
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced its financial results on Tuesday for the fir...
Best Quarterly Results in Company’s History from a Financial Perspective. EBITDA Improvements Driven by Record Revenues, Record Margins and Operational Efficiencies. Marketing Authorization of Trunerox™ in Colombia by INVIMA for Patients with LGS and DS in Colombia. ...
There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB), but treatments to help alleviate and control the symptoms d...